Patent ID: 8914239

Claim:
A method for determining a personalized medical intervention for an individual having a diagnosed pancreatic cancer comprising the steps of: a. measuring a molecular profile of at least one sample of the individual's pancreatic cancer comprising at least one of nucleic acid and protein analysis for each of the members of the molecular profile, wherein the members of the molecular profile comprise ERBB2, ESR1, TOP1, KIT, and EGFR; b. comparing the results of the at least one of nucleic acid and protein analysis in step a) to a reference to determine which members of the molecular profile exhibit a change as compared to the reference; c. accessing a computer database to identify at least one drug therapy that interacts with each of the members of the molecular profile that exhibited a change as compared to the reference in step b); and d. providing a computer generated report that indicates the at least one drug therapy identified in step c).